Comparison of the efficacy and safety of an oral combination of losartan, hydrochlorothiazide and simvastatin against separated components, in hypertensive and dyslipidemic patients
Emilio Exaire-Murad1, Luis Fernando Paredes-Fernández1, Jorge Antonio Aldrete-Velasco2, Elvira Isabel Nuño-Carral3, Juan Gerardo Reyes García4, Francisco Javier Flores-Murrieta4,5, Miriam del Carmen Carrasco-Portugal5 and Noemí Santos-Caballero6*
1Hospital General Dr. Enrique Cabrera Cosio, Mexico City, Mexico.
2Paracelsus S.A de C.V. Mexico City, Mexico.
3Fideicomiso de Fomento Minero, Mexico City, Mexico.
4Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Mexico City, Mexico.
5Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Secretaría de Salud, Mexico City, Mexico.
6Landsteiner Scientific, S.A. de C.V., México City, Mexico.
Email: [email protected]